Tech Company Financing Transactions

Lyric Pharmaceuticals Funding Round

Lyric Pharmaceuticals, operating out of South San Francisco, received $20.4 million from RiverVest Venture Partners, Sante Ventures and Third Point.

Transaction Overview

Company Name
Lyric Pharmaceuticals
Announced On
3/2/2015
Transaction Type
Venture Equity
Amount
$20,400,000
Round
Series A
Investors

RiverVest Venture Partners (Lead Investor) (Niall O'Donnell)

Sante Ventures (Lead Investor)

Third Point (Lead Investor)

Proceeds Purpose
The current financing will enable the company to perform two clinical studies, including a clinical proof of concept study, in addition to other supportive activities.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
601 Gateway Blvd. 1020
South San Francisco, CA 94080
USA
Phone
650-866-8070
Website
www.lyricpharma.com
Email Address
[email protected]
Overview
Lyric is a clinical stage company developing novel gastrointestinal therapeutics for unmet medical needs in the hospital setting.
Profile
Lyric Pharmaceuticals LinkedIn Company Profile
Social Media
Lyric Pharmaceuticals Company Twitter Account
Company News
Lyric Pharmaceuticals News
Facebook
Lyric Pharmaceuticals on Facebook
YouTube
Lyric Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Wurtman
  David Wurtman LinkedIn Profile  David Wurtman Twitter Account  David Wurtman News  David Wurtman on Facebook
Chief Financial Officer
Dana McGowan
  Dana McGowan LinkedIn Profile  Dana McGowan Twitter Account  Dana McGowan News  Dana McGowan on Facebook
Chief Marketing Officer
Scott Harris
  Scott Harris LinkedIn Profile  Scott Harris Twitter Account  Scott Harris News  Scott Harris on Facebook
Vice President
Scott Chadwick
  Scott Chadwick LinkedIn Profile  Scott Chadwick Twitter Account  Scott Chadwick News  Scott Chadwick on Facebook
Vice President
Kevin Kaster
  Kevin Kaster LinkedIn Profile  Kevin Kaster Twitter Account  Kevin Kaster News  Kevin Kaster on Facebook
VP - Bus. Development
Joyce James
  Joyce James LinkedIn Profile  Joyce James Twitter Account  Joyce James News  Joyce James on Facebook
VP - Operations
Randy Brown
  Randy Brown LinkedIn Profile  Randy Brown Twitter Account  Randy Brown News  Randy Brown on Facebook
VP - Regulatory Affairs
Meredith Brown-Tuttle
  Meredith Brown-Tuttle LinkedIn Profile  Meredith Brown-Tuttle Twitter Account  Meredith Brown-Tuttle News  Meredith Brown-Tuttle on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/2/2015: SKULLY venture capital transaction
Next: 3/2/2015: Twenty20 venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.